Trial intelligence / Profile preview

Smokefreetxt for Smoking Cessation in Substance Use Patients

NCT02665208Completed

Sponsor
NYU Langone Health
Start
Mar 2015
Primary completion
Sep 2015
Countries
1
01

Overview

Randomised, open-label trial in Tobacco Use Disorder (TUD) (2 arms), sponsored by NYU Langone Health. Primary endpoints: Difference in patient acceptability assessed via rates of participant adoption of TMI at 24 weeks, Feasibility measured by rates of retention in the TMI at 24 weeks and 1 more. Started Mar 2015; status: completed.

02

Conditions

Tobacco Use Disorder (TUD)

Beyond the preview

Go deeper on NCT02665208.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02665208.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call